DSGN Long Call Strategy
DSGN (Design Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Design Therapeutics, Inc. is a biopharmaceutical company in the preclinical phase that focuses on creating treatments for genetic conditions stemming from nucleotide repeat expansions. Its current pipeline targets Friedreich's Ataxia (FA), a severe, progressive, monogenic, and autosomal recessive disease. FA primarily impairs mitochondrial function across various organ systems, resulting in neurological, cardiac, and metabolic complications. Another significant area of development is Myotonic Dystrophy Type-1 (DM1). This is a progressive, dominantly inherited monogenic neuromuscular illness that impacts skeletal muscle, the heart, brain, and other bodily systems. Beyond these, the company is advancing its GeneTAC product candidate platform to address an array of other monogenic conditions caused by nucleotide repeat expansions.
DSGN (Design Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $833.8M, a beta of 1.66 versus the broader market, a 52-week range of 3.33-17.25, average daily share volume of 844K, a public-listing history dating back to 2021, approximately 56 full-time employees. These structural characteristics shape how DSGN stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.66 indicates DSGN has historically moved more than the broader market, amplifying both the directional payoff and the realized volatility relative to an index-equivalent position.
What is a long call on DSGN?
A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.
Current DSGN snapshot
As of June 29, 2026, spot at $14.40, ATM IV 113.50%, IV rank 16.07%, expected move 32.54%. The long call on DSGN below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this long call structure on DSGN specifically: DSGN IV at 113.50% is on the cheap side of its 1-year range, which favors premium-buying structures like a DSGN long call, with a market-implied 1-standard-deviation move of approximately 32.54% (roughly $4.69 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated DSGN expiries trade a higher absolute premium for lower per-day decay. Position sizing on DSGN should anchor to the underlying notional of $14.40 per share and to the trader's directional view on DSGN stock.
DSGN long call setup
The DSGN long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With DSGN near $14.40, the first option leg uses a $14.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed DSGN chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 DSGN shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $14.00 | $1.60 |
DSGN long call risk and reward
- Net Premium / Debit
- -$160.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$160.00
- Breakeven(s)
- $15.60
- Risk / Reward Ratio
- Unbounded
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.
DSGN long call payoff curve
Modeled P&L at expiration across a range of underlying prices for the long call on DSGN. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | -$160.00 |
| $3.19 | -77.8% | -$160.00 |
| $6.38 | -55.7% | -$160.00 |
| $9.56 | -33.6% | -$160.00 |
| $12.74 | -11.5% | -$160.00 |
| $15.92 | +10.6% | +$32.41 |
| $19.11 | +32.7% | +$350.69 |
| $22.29 | +54.8% | +$668.97 |
| $25.47 | +76.9% | +$987.25 |
| $28.66 | +99.0% | +$1,305.53 |
When traders use long call on DSGN
Long calls on DSGN express a bullish thesis with defined risk; traders use them ahead of DSGN catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
DSGN thesis for this long call
The market-implied 1-standard-deviation range for DSGN extends from approximately $9.71 on the downside to $19.09 on the upside. A DSGN long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current DSGN IV rank near 16.07% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on DSGN at 113.50%. As a Healthcare name, DSGN options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to DSGN-specific events.
DSGN long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. DSGN positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move DSGN alongside the broader basket even when DSGN-specific fundamentals are unchanged. Long-premium structures like a long call on DSGN are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current DSGN chain quotes before placing a trade.
Frequently asked questions
- What is a long call on DSGN?
- A long call on DSGN is the long call strategy applied to DSGN (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With DSGN stock trading near $14.40, the strikes shown on this page are snapped to the nearest listed DSGN chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are DSGN long call max profit and max loss calculated?
- Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the DSGN long call priced from the end-of-day chain at a 30-day expiry (ATM IV 113.50%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$160.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a DSGN long call?
- The breakeven for the DSGN long call priced on this page is roughly $15.60 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current DSGN market-implied 1-standard-deviation expected move is approximately 32.54%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a long call on DSGN?
- Long calls on DSGN express a bullish thesis with defined risk; traders use them ahead of DSGN catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
- How does current DSGN implied volatility affect this long call?
- DSGN ATM IV is at 113.50% with IV rank near 16.07%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.